BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

ARKGvsPSCHETF Comparison

ETF 1

ARKG

ARK Genomic Revolution ETF

This fund is part of

BioTech & Genomics

-0.14%

Full ARKG fund page

VS

ETF 2

PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of

US Health Care

-0.03%

Full PSCH fund page

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, PSCH's top sector exposures are Health Care ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.29% for PSCH. ARKG is up 2.44% year-to-date (YTD) with -$37M in YTD flows. PSCH performs worse with 1.6% YTD performance, and -$19M in YTD flows. Run a side-by-side ETF comparison of ARKG and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

ARKG vs PSCH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 04/27/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	ARKG PSCH	+19.74%+14.25%	-7.79%+0.97%	+2.44%+1.60%	+33.74%+8.95%	+3.79%+1.45%	-67.31%-29.04%
Flows	ARKG PSCH	-$22M-$4M	-$94M-$18M	-$37M-$19M	-$81M-$33M	-$609M-$154M	-$3.04B-$237M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	ARKG PSCH	+42.80%+23.35%	+41.55%+20.91%	+42.57%+21.73%	+45.35%+22.88%
Max drawdown	ARKG PSCH	-23.56%-12.32%	-27.52%-15.36%	-51.98%-22.80%	-80.16%-47.23%
Max drawdown duration	ARKG PSCH	90d81d	95d127d	1013d433d	1763d1766d

Trading data

Create an account to view trading data

Join for free

	ARKG	PSCH
Last sale 4/29/2026 at 1:30 PM	$28.53	$43.95
Previous close 04/28/2026	$29.58	$44.77
Consolidated volume 04/28/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of March 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	ARKG	PSCH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 4/29/2026 at 1:30 PM

Live

Closed

	ARKG	PSCH
Last price	$28.53	$43.95
1D performance	-3.55%	-1.83%
AuM	$1.16 B	$129.45 M
E/R	0.75%	0.29%

Characteristics

	ARKG	PSCH
Management strategy	Active	Passive
Provider	Ark Investment	Invesco
Benchmark	-	S&P SmallCap 600 Capped Health Care Index
N° of holdings	27	71
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	April 2, 2019	April 7, 2010
ESG	No	No

More ARKG data on Trackinsight

More PSCH data on Trackinsight

Exposure

Countries

ARKG

USA

70.4%

Switzerland

9.23%

Other

20.37%

PSCH

USA

96.2%

Other

3.8%

Sectors

ARKG

Health Care

78.38%

Other

21.62%

PSCH

Health Care

90.59%

Other

9.41%

Diversification

ARKG

Total weight of top 15 holdings out of 15

62.5%

PSCH

Total weight of top 15 holdings out of 15

44.68%

Top 15 holdings

Data as of March 31, 2026

ARKG

CRISPR THERAPEUTICS

9.23%

10X GENOMICS INC

6.30%

BEAM THERAPEUTICS

4.86%

PERSONALIS INC

4.69%

NATERA

4.48%

ILLUMINA

4.45%

GUARDANT HEALTH INC

4.21%

INTELLIA THERAPEUTICS INC

3.58%

CAREDX INC/D

3.56%

RECURSION PHARMACEUTICALS

3.54%

ABSCI

3.27%

VERACYTE INC/D

2.98%

ADAPTIVE BIOTECHNOLOGIES

2.71%

NURIX THERAPEUTICS

2.45%

SEMA4 HOLDINGS CORP

2.19%

PSCH

MOLINA HLTHCRE

4.25%

KRYSTAL BIOTECH INC

3.90%

GLAUKOS

3.65%

PROTAGONIST THERAPEUTICS INC

3.58%

US10950A1060

3.45%

PTC THERAPEUTI/D

3.27%

TELEFLEX

3.16%

ALKERMES

2.99%

TG THERAPEUTICS

2.66%

MERIT MEDICAL SYSTEMS

2.51%

RADNET

2.41%

LIGAND PHARMACEUTICALS

2.37%

US45579U1097

2.23%

CORCEPT THERAPEUTICS

2.17%

TRANSMEDICS GROUP

2.08%

Frequently asked questions about ARKG and PSCH

How have the ARKG and PSCH ETFs performed in 2026?

As of April 27, 2026, ARKG is up 2.44% year-to-date (YTD), while PSCH has returned 1.6%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or PSCH?

Year-to-date, the ARKG ETF saw -$37M in flows, compared to -$19M for PSCH.

Which ETF is more volatile: ARKG or PSCH?

Over the past year, ARKG had a volatility of 41.55%, while PSCH experienced 20.91%.

Which ETF is bigger: ARKG or PSCH?

As of April 27, 2026, ARKG holds $1.16 B in assets under management (AUM), while PSCH manages $129.45 M.

What sectors do the ARKG and PSCH ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, PSCH focuses on Health Care.

What are the top holdings of the ARKG ETF and PSCH ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. PSCH holds in its top three: MOLINA HLTHCRE, KRYSTAL BIOTECH INC and GLAUKOS.

Which ETF is more diversified: ARKG or PSCH?

ARKG holds 27 securities with 62.5% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 44.68%.

Biotech ETFs – Investing in Health Innovation

July 21, 2022

ARKG

ARKGvsPSCHETF Comparison

ARK Genomic Revolution ETF

Invesco S&P SmallCap Health Care ETF

ARKG vs PSCH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the ARKG and PSCH ETFs performed in 2026?

As of April 27, 2026, ARKG is up 2.44% year-to-date (YTD), while PSCH has returned 1.6%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or PSCH?

Year-to-date, the ARKG ETF saw -$37M in flows, compared to -$19M for PSCH.

Which ETF is more volatile: ARKG or PSCH?

Over the past year, ARKG had a volatility of 41.55%, while PSCH experienced 20.91%.

Which ETF is bigger: ARKG or PSCH?

As of April 27, 2026, ARKG holds $1.16 B in assets under management (AUM), while PSCH manages $129.45 M.

What sectors do the ARKG and PSCH ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, PSCH focuses on Health Care.

What are the top holdings of the ARKG ETF and PSCH ETF?

ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. PSCH holds in its top three: MOLINA HLTHCRE, KRYSTAL BIOTECH INC and GLAUKOS.

Which ETF is more diversified: ARKG or PSCH?

ARKG holds 27 securities with 62.5% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 44.68%.

Biotech ETFs – Investing in Health Innovation

Expert-Built ETF Portfolios, All in One Place